Participants 110 162 4
A multicenter, randomized, open-label study in China
Participants 293 352 4
in on-demand therapy for non-erosive reflux disease (NERD).
Participants 459 522 4
Patients who had complete symptom relief in the initial therapy
Participants 1006 1206 6
398 patients were recruited in the initial therapy group, among whom 253 were included in on-demand therapy, with 127 patients in the hydrotalcite group and the remaining 126 in the esomeprazole group
Participants 1632 1667 3
 of on-demand therapy for NERD pati
